252 related articles for article (PubMed ID: 25740948)
1. Noncanonical STAT3 activation regulates excess TGF-β1 and collagen I expression in muscle of stricturing Crohn's disease.
Li C; Iness A; Yoon J; Grider JR; Murthy KS; Kellum JM; Kuemmerle JF
J Immunol; 2015 Apr; 194(7):3422-31. PubMed ID: 25740948
[TBL] [Abstract][Full Text] [Related]
2. Increased activation of latent TGF-β1 by αVβ3 in human Crohn's disease and fibrosis in TNBS colitis can be prevented by cilengitide.
Li C; Flynn RS; Grider JR; Murthy KS; Kellum JM; Akbari H; Kuemmerle JF
Inflamm Bowel Dis; 2013 Dec; 19(13):2829-39. PubMed ID: 24051933
[TBL] [Abstract][Full Text] [Related]
3. Endogenous IGFBP-3 regulates excess collagen expression in intestinal smooth muscle cells of Crohn's disease strictures.
Flynn RS; Mahavadi S; Murthy KS; Grider JR; Kellum JM; Akbari H; Kuemmerle JF
Inflamm Bowel Dis; 2011 Jan; 17(1):193-201. PubMed ID: 20848532
[TBL] [Abstract][Full Text] [Related]
4. Increased IGF-IEc expression and mechano-growth factor production in intestinal muscle of fibrostenotic Crohn's disease and smooth muscle hypertrophy.
Li C; Vu K; Hazelgrove K; Kuemmerle JF
Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(11):G888-99. PubMed ID: 26428636
[TBL] [Abstract][Full Text] [Related]
5. Endoplasmic Reticulum Stress in Subepithelial Myofibroblasts Increases the TGF-β1 Activity That Regulates Fibrosis in Crohn's Disease.
Li C; Grider JR; Murthy KS; Bohl J; Rivet E; Wieghard N; Kuemmerle JF
Inflamm Bowel Dis; 2020 May; 26(6):809-819. PubMed ID: 32031621
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of excess collagen IαI, fibrosis, and smooth muscle growth in TNBS-induced colitis in IGF-I(+/-) mice.
Mahavadi S; Flynn RS; Grider JR; Qiao LY; Murthy KS; Hazelgrove KB; Kuemmerle JF
Inflamm Bowel Dis; 2011 Mar; 17(3):711-9. PubMed ID: 20722057
[TBL] [Abstract][Full Text] [Related]
7. Intestinal Activation of pH-Sensing Receptor OGR1 [GPR68] Contributes to Fibrogenesis.
Hutter S; van Haaften WT; Hünerwadel A; Baebler K; Herfarth N; Raselli T; Mamie C; Misselwitz B; Rogler G; Weder B; Dijkstra G; Meier CF; de Vallière C; Weber A; Imenez Silva PH; Wagner CA; Frey-Wagner I; Ruiz PA; Hausmann M
J Crohns Colitis; 2018 Nov; 12(11):1348-1358. PubMed ID: 30165600
[TBL] [Abstract][Full Text] [Related]
8. Role of Interleukin-17 in Pathogenesis of Intestinal Fibrosis in Mice.
Li J; Liu L; Zhao Q; Chen M
Dig Dis Sci; 2020 Jul; 65(7):1971-1979. PubMed ID: 31808003
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic analysis of intestinal fibrosis-associated gene expression in response to medical therapy in Crohn's disease.
Burke JP; Ferrante M; Dejaegher K; Watson RW; Docherty NG; De Hertogh G; Vermeire S; Rutgeerts P; D'Hoore A; Penninckx F; Geboes K; Van Assche G; O'Connell PR
Inflamm Bowel Dis; 2008 Sep; 14(9):1197-204. PubMed ID: 18452219
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
[TBL] [Abstract][Full Text] [Related]
11. Ethanol-stimulated differentiated functions of human or mouse hepatic stellate cells are mediated by connective tissue growth factor.
Chen L; Charrier AL; Leask A; French SW; Brigstock DR
J Hepatol; 2011 Aug; 55(2):399-406. PubMed ID: 21156189
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
[TBL] [Abstract][Full Text] [Related]
13. Structural and molecular features of intestinal strictures in rats with Crohn's-like disease.
Talapka P; Berkó A; Nagy LI; Chandrakumar L; Bagyánszki M; Puskás LG; Fekete É; Bódi N
World J Gastroenterol; 2016 Jun; 22(22):5154-64. PubMed ID: 27298558
[TBL] [Abstract][Full Text] [Related]
14. Expression and regulation of connective tissue growth factor by transforming growth factor beta and tumour necrosis factor alpha in fibroblasts isolated from strictures in patients with Crohn's disease.
Beddy D; Mulsow J; Watson RW; Fitzpatrick JM; O'Connell PR
Br J Surg; 2006 Oct; 93(10):1290-6. PubMed ID: 16838391
[TBL] [Abstract][Full Text] [Related]
15. Intestinal myofibroblast TRPC6 channel may contribute to stenotic fibrosis in Crohn's disease.
Kurahara LH; Sumiyoshi M; Aoyagi K; Hiraishi K; Nakajima K; Nakagawa M; Hu Y; Inoue R
Inflamm Bowel Dis; 2015 Mar; 21(3):496-506. PubMed ID: 25647156
[TBL] [Abstract][Full Text] [Related]
16. IL-10 is not anti-fibrotic but pro-fibrotic in endometriosis: IL-10 treatment of endometriotic stromal cells in vitro promotes myofibroblast proliferation and collagen type I protein expression.
Matsuzaki S; Pouly JL; Canis M
Hum Reprod; 2023 Jan; 38(1):14-29. PubMed ID: 36413036
[TBL] [Abstract][Full Text] [Related]
17. In Crohn's disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts.
Nijhuis A; Biancheri P; Lewis A; Bishop CL; Giuffrida P; Chan C; Feakins R; Poulsom R; Di Sabatino A; Corazza GR; MacDonald TT; Lindsay JO; Silver AR
Clin Sci (Lond); 2014 Sep; 127(5):341-50. PubMed ID: 24641356
[TBL] [Abstract][Full Text] [Related]
18. Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid.
Latella G; Sferra R; Vetuschi A; Zanninelli G; D'Angelo A; Catitti V; Caprilli R; Gaudio E
Eur J Clin Invest; 2008 Jun; 38(6):410-20. PubMed ID: 18489401
[TBL] [Abstract][Full Text] [Related]
19. Tissue inhibitor of metalloproteinase-3 regulates inflammation in human and mouse intestine.
Monteleone I; Federici M; Sarra M; Franzè E; Casagrande V; Zorzi F; Cavalera M; Rizzo A; Lauro R; Pallone F; MacDonald TT; Monteleone G
Gastroenterology; 2012 Nov; 143(5):1277-1287.e4. PubMed ID: 22819866
[TBL] [Abstract][Full Text] [Related]
20. Verapamil inhibited the development of ureteral stricture by blocking CaMK II-mediated STAT3 and Smad3/JunD pathways.
Qing Z; Yuan W; Wang J; Song W; Luo J; Wu X; Lu Q; Li Y; Zeng M
Int Urol Nephrol; 2022 Nov; 54(11):2855-2866. PubMed ID: 35922702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
